March 31 (SeeNews) - Bulgarian blue-chip drug maker Sopharma on Monday said it has acquired 51% of Serbian pharmaceutical firm Ivancic and Sons, and not 90% as it had reported earlier, for an undisclosed price.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
